Serum from patients with hepatitis E virus-related acute liver failure induces human liver cell apoptosis

Wu,Fan; Wang,Minxin; Tian,Deying

doi:10.3892/etm.2013.1398

Serum from patients with hepatitis E virus-related acute liver failure induces human liver cell apoptosis

Authors:
- Fan Wu
- Minxin Wang
- Deying Tian
View Affiliations

Affiliations: Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: November 11, 2013 https://doi.org/10.3892/etm.2013.1398
Pages: 300-304

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The pathogenesis of acute liver failure has not been fully elucidated. The present study investigated the effects of the serum from patients with hepatitis E virus (HEV)-related acute liver failure on human liver cell survival and apoptosis, and evaluated the protective effects of anti-lipopolysaccharide(LPS) antibody recognizing core polysaccharide against acute liver failure serum‑induced apoptosis. Serum was collected from patients with HEV-related acute liver failure. The levels of endotoxin (LPS) in the serum were measured using a quantitative tachypleus amebocyte lysate endotoxin detection kit with a chromogenic endpoint. Serum with a mean concentration of LPS was incubated with L02 human liver cells and the rate of apoptosis was detected by flow cytometry. The apoptotic rate was also evaluated in liver cells incubated with antibody and the HEV-related acute liver failure serum. The results indicated that the concentration of LPS in the serum of patients with HEV-related acute liver failure was 0.26±0.02 EU/ml, which was significantly higher than that of the control group (P<0.05). The rate of apoptosis in the human liver cells induced by acute liver failure serum was 5.83±0.42%, which was significantly increased compared with that in the cells treated with the serum of healthy individuals (P<0.05). The apoptotic rate of the cells incubated with antibody and the acute liver failure serum was 5.53±0.51%, which was lower than that of the cells incubated with acute liver failure serum alone (P>0.05). These results indicate that the serum of patients with HEV-related acute liver failure induces the apoptosis of human liver cells. LPS may be directly involved in the apoptosis of human liver cells. Moreover, the presence of the antibody did not significantly reduce the level of apoptosis of liver cells exposed to HEV-related acute liver failure serum.

View Figures

View References

1	Lee WM: Acute liver failure. Semin Respir Crit Care Med. 33:36–45. 2012. View Article : Google Scholar
2	Mas A and Rodés J: Fulminant hepatic failure. Lancet. 349:1081–1085. 1997. View Article : Google Scholar
3	Macnaughtan J and Thomas H: Liver failure at the front door. Clin Med. 10:73–78. 2010. View Article : Google Scholar : PubMed/NCBI
4	Neuberger J: Prediction of survival for patients with fulminant hepatic failure. Hepatology. 41:19–22. 2005. View Article : Google Scholar : PubMed/NCBI
5	Bernal W, Auzinger G, Dhawan A and Wendon J: Acute liver failure. Lancet. 376:190–201. 2010. View Article : Google Scholar
6	Tanaka Y, Takahashi K, Orito E, et al: Molecular tracing of Japan-indigenous hepatitis E viruses. J Gen Virol. 87:949–954. 2006. View Article : Google Scholar : PubMed/NCBI
7	Li TC, Chijiwa K, Sera N, et al: Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis. 11:1958–1960. 2005. View Article : Google Scholar : PubMed/NCBI
8	Chau TN, Lai ST, Tse C, et al: Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol. 101:292–296. 2006. View Article : Google Scholar : PubMed/NCBI
9	Togo S, Kubota T, Matsuo K, et al: Mechanism of liver failure after hepatectomy. Nihon Geka Gakkai Zasshi. 105:658–663. 2004.(In Japanese).
10	Pathil A, Warth A, Chamulitrat W and Stremmel W: The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury. J Hepatol. 54:674–684. 2011.PubMed/NCBI
11	McCloskey P, Tootle R, Selden C, Larsen F, Roberts E and Hodgson HJ: Modulation of hepatocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma. Artif Organs. 26:340–348. 2002. View Article : Google Scholar : PubMed/NCBI
12	Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J and Williams R: The systemic inflammatory response syndrome in acute liver failure. Hepatology. 32:734–739. 2000. View Article : Google Scholar : PubMed/NCBI
13	Rolando N, Harvey F, Brahm J, et al: Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 11:49–53. 1990. View Article : Google Scholar : PubMed/NCBI
14	Vaquero J, Polson J, Chung C, et al: Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 125:755–764. 2003. View Article : Google Scholar : PubMed/NCBI
15	Kamimoto M, Mizuno S and Nakamura T: Reciprocal regulation of IL-6 and IL-10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia. Int J Mol Med. 24:161–170. 2009.PubMed/NCBI
16	McAvoy EF, McDonald B, Parsons SA, Wong CH, Landmann R and Kubes P: The role of CD14 in neutrophil recruitment within the liver microcirculation during endotoxemia. J Immunol. 186:2592–2601. 2011. View Article : Google Scholar : PubMed/NCBI
17	Raulf-Heimsoth M, Liebers V and Brüning T: Mechanism of endotoxin action and pattern of diseases. Gefahrstoffe Reinhaltung Der Luft. 67:351–353. 2007.(In German).
18	Li T, Hu J, Thomas JA and Li L: Differential induction of apoptosis by LPS and taxol in monocytic cells. Mol Immunol. 42:1049–1055. 2005. View Article : Google Scholar : PubMed/NCBI
19	Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL and Williams R: Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 2:72–74. 1988. View Article : Google Scholar : PubMed/NCBI
20	Jalan R, Olde Damink S, Hayes PC, Deutz NEP and Lee A: Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol. 41:613–620. 2004. View Article : Google Scholar
21	Han DW: Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol. 8:961–965. 2002.PubMed/NCBI
22	Warren HS, Amato SF, Fitting C, et al: Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med. 177:89–97. 1993. View Article : Google Scholar : PubMed/NCBI
23	Newsome PN, Tsiaoussis J, Masson S, et al: Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology. 40:636–645. 2004. View Article : Google Scholar : PubMed/NCBI
24	Du WB, Pan XP, Yu XP, et al: Effects of plasma from patients with acute on chronic liver failure on function of cytochrome P450 in immortalized human hepatocytes. Hepatobiliary Pancreat Dis Int. 9:611–614. 2010.PubMed/NCBI
25	Chen M, Zhou J, Li H, Chen A, Zhang Z and Tian D: Effects of endotoxin on liver Smac apoptosis channel. J Huazhong Univ Sci Technolog Med Sci. 28:660–664. 2008. View Article : Google Scholar : PubMed/NCBI
26	Nie B, Park HM, Kazantzis M, et al: Specific bile acids inhibit hepatic fatty acid uptake in mice. Hepatology. 56:1300–1310. 2012. View Article : Google Scholar : PubMed/NCBI
27	Li T, Jahan A and Chiang JY: Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-Jun pathway in human liver cells. Hepatology. 43:1202–1210. 2006. View Article : Google Scholar : PubMed/NCBI
28	Reinehr R and Häussinger D: Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95. Gastroenterology. 126:249–262. 2004. View Article : Google Scholar : PubMed/NCBI
29	Karimian G, Buist-Homan M, Mikus B, Henning RH, Faber KN and Moshage H: Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis. PLoS One. 7:e526472012. View Article : Google Scholar : PubMed/NCBI
30	Mayorga M, Iborra A, Estany S and Martínez P: Protective effect of vitamin E in an animal model of LPS-induced inflammation. Am J Reprod Immunol. 52:356–361. 2004. View Article : Google Scholar : PubMed/NCBI
31	McGhee JR, Kiyono H, Michalek SM, Babb JL, Rosenstreich DL and Mergenhagen SE: Lipopolysaccharide (LPS) regulation of the immune response: T lymphocytes from normal mice suppress mitogenic and immunogenic responses to LPS. J Immunol. 124:1603–1611. 1980.PubMed/NCBI
32	Hitchcock PJ, Leive L, Mäkelä PH, Rietschel ET, Strittmatter W and Morrison DC: Lipopolysaccharide nomenclature - past, present, and future. J Bacteriol. 166:699–705. 1986.PubMed/NCBI
33	Lachman E, Pitsoe SB and Gaffin SL: Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin. Lancet. 1:981–983. 1984. View Article : Google Scholar : PubMed/NCBI
34	Ziegler EJ, Fisher CJ Jr, Sprung CL, et al; The HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med. 324:429–436. 1991. View Article : Google Scholar
35	Recknagel P, Gonnert FA, Halilbasic E, et al: Mechanisms and functional consequences of liver failure substantially differ between endotoxaemia and faecal peritonitis in rats. Liver Int. 33:283–293. 2013. View Article : Google Scholar : PubMed/NCBI